Abivax Socit Anonyme Stock Performance
| AAVXF Stock | USD 11.05 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and ABIVAX Socit are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ABIVAX Socit Anonyme has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ABIVAX Socit is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 29.3 M | |
| Total Cashflows From Investing Activities | -1.5 M |
ABIVAX |
ABIVAX Socit Relative Risk vs. Return Landscape
If you would invest 1,105 in ABIVAX Socit Anonyme on August 24, 2024 and sell it today you would earn a total of 0.00 from holding ABIVAX Socit Anonyme or generate 0.0% return on investment over 90 days. ABIVAX Socit Anonyme is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than ABIVAX, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
ABIVAX Socit Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABIVAX Socit's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as ABIVAX Socit Anonyme, and traders can use it to determine the average amount a ABIVAX Socit's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AAVXF |
Based on monthly moving average ABIVAX Socit is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABIVAX Socit by adding ABIVAX Socit to a well-diversified portfolio.
ABIVAX Socit Fundamentals Growth
ABIVAX Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ABIVAX Socit, and ABIVAX Socit fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABIVAX Pink Sheet performance.
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | 4.66 % | |||
| Current Valuation | 165.28 M | |||
| Shares Outstanding | 22.3 M | |||
| Price To Earning | (7.88) X | |||
| Price To Book | 27.57 X | |||
| Price To Sales | 20.65 X | |||
| Revenue | 37 K | |||
| EBITDA | (42.25 M) | |||
| Cash And Equivalents | 26.57 M | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 53.45 M | |||
| Debt To Equity | 8.03 % | |||
| Book Value Per Share | 0.36 X | |||
| Cash Flow From Operations | (45.66 M) | |||
| Earnings Per Share | (2.59) X | |||
| Total Asset | 110.36 M | |||
About ABIVAX Socit Performance
By analyzing ABIVAX Socit's fundamental ratios, stakeholders can gain valuable insights into ABIVAX Socit's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ABIVAX Socit has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ABIVAX Socit has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.Things to note about ABIVAX Socit Anonyme performance evaluation
Checking the ongoing alerts about ABIVAX Socit for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ABIVAX Socit Anonyme help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ABIVAX Socit Anonyme generated a negative expected return over the last 90 days | |
| ABIVAX Socit Anonyme has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 37 K. Net Loss for the year was (41.36 M) with loss before overhead, payroll, taxes, and interest of (45.52 M). | |
| ABIVAX Socit Anonyme has accumulated about 26.57 M in cash with (45.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58. | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ABIVAX Socit's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABIVAX Socit's stock is overvalued or undervalued compared to its peers.
- Examining ABIVAX Socit's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABIVAX Socit's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABIVAX Socit's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ABIVAX Socit's pink sheet. These opinions can provide insight into ABIVAX Socit's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |